15.00
price down icon0.73%   -0.11
after-market After Hours: 15.00
loading
Dr Reddys Laboratories Ltd Adr stock is traded at $15.00, with a volume of 388.41K. It is down -0.73% in the last 24 hours and down -4.15% over the past month. Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
See More
Previous Close:
$15.11
Open:
$15.1
24h Volume:
388.41K
Relative Volume:
0.52
Market Cap:
$2.52B
Revenue:
$3.47B
Net Income/Loss:
$668.83M
P/E Ratio:
4.039
EPS:
3.7138
Net Cash Flow:
$253.46M
1W Performance:
+1.37%
1M Performance:
-4.15%
6M Performance:
+8.43%
1Y Performance:
+14.59%
1-Day Range:
Value
$15.00
$15.19
1-Week Range:
Value
$14.52
$15.40
52-Week Range:
Value
$12.90
$16.89

Dr Reddys Laboratories Ltd Adr Stock (RDY) Company Profile

Name
Name
Dr Reddys Laboratories Ltd Adr
Name
Phone
-
Name
Address
-
Name
Employee
27,048
Name
Twitter
@drreddys
Name
Next Earnings Date
2024-11-05
Name
Latest SEC Filings
Name
RDY's Discussions on Twitter

Dr Reddys Laboratories Ltd Adr Stock (RDY) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-11-24 Downgrade Jefferies Buy → Underperform
Aug-29-23 Downgrade HSBC Securities Buy → Hold
May-18-23 Downgrade Bernstein Outperform → Mkt Perform
Mar-17-23 Upgrade BofA Securities Neutral → Buy
Jan-30-23 Initiated JP Morgan Underweight
Nov-14-22 Downgrade Credit Suisse Neutral → Underperform
Jan-03-22 Resumed BofA Securities Neutral
Jul-27-21 Downgrade Credit Suisse Outperform → Neutral
Feb-02-21 Upgrade Barclays Equal Weight → Overweight
Sep-18-20 Upgrade BofA Securities Neutral → Buy
Sep-18-20 Upgrade Investec Sell → Hold
Jan-28-20 Downgrade CLSA Buy → Outperform
Jan-27-20 Downgrade CLSA Buy → Outperform
Jan-09-20 Upgrade Citigroup Sell → Buy
Nov-04-19 Downgrade BofA/Merrill Buy → Neutral
Sep-04-19 Upgrade Credit Suisse Underperform → Outperform
Jul-01-19 Upgrade Macquarie Neutral → Outperform
Jun-20-19 Initiated Deutsche Bank Hold
Jun-11-19 Initiated Barclays Equal Weight
May-20-19 Downgrade Morgan Stanley Overweight → Equal-Weight
Feb-19-19 Upgrade CLSA Outperform → Buy
Jan-17-19 Downgrade Citigroup Neutral → Sell
Sep-21-17 Upgrade Morgan Stanley Equal-Weight → Overweight
Aug-31-17 Upgrade CLSA Underperform → Outperform
Jul-28-17 Downgrade CLSA Underperform → Sell
Jul-27-16 Downgrade HSBC Securities Hold → Reduce
Jul-27-16 Downgrade Jefferies Hold → Underperform
Feb-10-16 Upgrade Credit Agricole Underperform → Buy
Nov-10-15 Downgrade Citigroup Buy → Neutral
View All

Dr Reddys Laboratories Ltd Adr Stock (RDY) Latest News

pulisher
Nov 08, 2024

ADR, GDR Listings of Indian companies - Goodreturns

Nov 08, 2024
pulisher
Nov 07, 2024

Earnings call: Dr. Reddy's reports robust growth and strategic expansions - Investing.com

Nov 07, 2024
pulisher
Nov 07, 2024

Earnings call: Dr. Reddy's reports robust growth and strategic expansions By Investing.com - Investing.com UK

Nov 07, 2024
pulisher
Nov 06, 2024

Zollinger-Ellison Syndrome (Gastrinoma) Global Clinical Trials Review 2024: Country (G7 & E7), Phase, Trial Status, End Points Status and Sponsor Type - GlobeNewswire Inc.

Nov 06, 2024
pulisher
Nov 06, 2024

Dr. Reddy's stock poised for recovery with new US launches and global OTC gains—BofA - Investing.com India

Nov 06, 2024
pulisher
Nov 05, 2024

Dr. Reddy’s Labs ADR earnings missed by $0.85, revenue topped estimates - Investing.com

Nov 05, 2024
pulisher
Oct 18, 2024

Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Friday Trading - MSN

Oct 18, 2024
pulisher
Oct 17, 2024

Infosys, Wipro ADRs down 3% on NYSE after Q2 results even as S&P, Dow drift near record-highs | Stock Market News - Mint

Oct 17, 2024
pulisher
Oct 17, 2024

Zacks Research Issues Positive Forecast for RDY Earnings - MarketBeat

Oct 17, 2024
pulisher
Oct 16, 2024

Top gainers and losers for today on October 16: HDFC Life, Dr Reddy’s Labs, Grasim lead NIFTY movers - Upstox

Oct 16, 2024
pulisher
Oct 11, 2024

Denmark Basal Cell Carcinoma Treatment Market Size & Outlook, 2030 - Grand View Research

Oct 11, 2024
pulisher
Oct 11, 2024

Saudi Arabia Basal Cell Carcinoma Treatment Market Size & Outlook, 2030 - Grand View Research

Oct 11, 2024
pulisher
Oct 05, 2024

Side-effects of banned drug Nimesulide still reported in children: Report | Today News - Mint

Oct 05, 2024
pulisher
Oct 04, 2024

Dr. Reddy’s Announces Share Subdivision Date - TipRanks

Oct 04, 2024
pulisher
Oct 02, 2024

Dr. Reddy’s Subsidiary Chirotech Dissolved - TipRanks

Oct 02, 2024
pulisher
Sep 30, 2024

Haryana Elections 2024: Capt. Abhimanyu, Savitri Jindal among wealthiest candidates for October 5 polls | Mint - Mint

Sep 30, 2024
pulisher
Sep 28, 2024

Assam: Mobile internet services to be disabled for eight hours on Sunday, here's why | Today News - Mint

Sep 28, 2024
pulisher
Sep 25, 2024

Apni Party's Altaf Bukhari, BJP's Devender Rana among 3 richest candidates in Jammu and Kashmir assembly poll fray | Mint - Mint

Sep 25, 2024
pulisher
Sep 24, 2024

Dr. Reddy's Labs ADR Sees RS Rating Rise To 72 - Investor's Business Daily

Sep 24, 2024
pulisher
Sep 23, 2024

Dr. Reddy’s Empowers Employees with Stock Options - TipRanks

Sep 23, 2024
pulisher
Sep 19, 2024

Deutsche Bank Appointed as Depositary Bank for the Sponsored American Depositary Receipt Program of Radiopharm Theranostics Limited - Business Wire

Sep 19, 2024
pulisher
Sep 19, 2024

Mondrian Investment Partners LTD Has $11.56 Million Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY) - MarketBeat

Sep 19, 2024
pulisher
Sep 18, 2024

Dr. Reddy's Laboratories Share Price Today Live Updates: Dr. Reddy's Laboratories Sees 1.48% Decline, Cu... - The Economic Times

Sep 18, 2024
pulisher
Sep 16, 2024

Dr. Reddy's Laboratories Share Price Live Updates: Dr. Reddy's Laboratories Sees Minor Price Dip Amidst ... - The Economic Times

Sep 16, 2024
pulisher
Sep 12, 2024

Dr. Reddy’s Shareholders Approve Stock Split - TipRanks

Sep 12, 2024
pulisher
Sep 06, 2024

US FDA closes inspection of Dr Reddy’s API unit - BusinessLine

Sep 06, 2024
pulisher
Sep 04, 2024

Mexico Antiviral Drugs Market Size & Outlook, 2022-2030 - Grand View Research

Sep 04, 2024
pulisher
Sep 04, 2024

The United States Antiviral Drugs Market Size & Outlook, 2030 - Grand View Research

Sep 04, 2024
pulisher
Sep 04, 2024

Latin America Antiviral Drugs Market Size & Outlook, 2030 - Grand View Research

Sep 04, 2024
pulisher
Sep 03, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Sep 03, 2024
pulisher
Sep 03, 2024

Dr. Reddy's Stock Hit All-Time High Last Month. Ready To Climb Again? - Investor's Business Daily

Sep 03, 2024
pulisher
Sep 03, 2024

The United States Erythropoietin Drugs Market Size & Outlook, 2030 - Grand View Research

Sep 03, 2024
pulisher
Aug 30, 2024

Volume Updates: Dr. Reddy's Laboratories Sees Significant Surge in Trading Volume - The Economic Times

Aug 30, 2024
pulisher
Aug 29, 2024

Dr. Reddy’s Approves Employee Share Allotment - TipRanks

Aug 29, 2024
pulisher
Aug 26, 2024

Stocks in news: Interarch, Dr Reddy's Labs, Ceigall, ONGC, Akums, Trent, Zydus Life & Uno Minda - Business Today

Aug 26, 2024
pulisher
Aug 21, 2024

Dr. Reddy's (RDY), Kainomyx Sign Potential Deal for Malaria Drug - Yahoo Finance

Aug 21, 2024
pulisher
Aug 20, 2024

Depository receipts regime fails to take off due to Sebi concerns | Mint - Mint

Aug 20, 2024
pulisher
Aug 14, 2024

China Biosimilars Market Size & Outlook, 2020-2027 - Grand View Research

Aug 14, 2024
pulisher
Aug 14, 2024

Buy or sell: Dr Reddy's to HCL Tech, Vaishali Parekh recommends three stocks to buy today — 14 August | Stock Market News - Mint

Aug 14, 2024
pulisher
Aug 12, 2024

Dr Reddy's Labs shares drop after US FDA gives VIA tag to Vizag facilities - Business Standard

Aug 12, 2024
pulisher
Aug 08, 2024

Form N-CSRS Northern Lights Fund For: May 31 - StreetInsider.com

Aug 08, 2024
pulisher
Aug 02, 2024

1:5 Split: Mega Pharma Makes Big Acquisition Update; LIC's 92,10,387 Shares To Become 4,60,51,935 Shares; BUY? - Goodreturns

Aug 02, 2024
pulisher
Aug 01, 2024

Lenovo Accelerates ‘Smarter AI for All’ with Databricks Collaboration - Business Wire

Aug 01, 2024
pulisher
Jul 30, 2024

Dr Reddy's Laboratories Ltd (RDY) Q1 2025 Earnings Call Transcri - GuruFocus.com

Jul 30, 2024

Dr Reddys Laboratories Ltd Adr Stock (RDY) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$84.08
price down icon 3.91%
$14.27
price up icon 1.42%
$91.57
price up icon 0.31%
$59.46
price up icon 0.08%
$127.17
price up icon 1.14%
$13.09
price up icon 1.00%
Cap:     |  Volume (24h):